Cargando…

Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic neoplasm. Surgery is the factual curative option, but most patients present with advanced disease. In order to increase resectability, results of neoadjuvant chemotherapy (NAC) on metastatic disease were extrapolated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fossaert, Violette, Mimmo, Antonio, Rhaiem, Rami, Rached, Linda J., Brasseur, Mathilde, Brugel, Mathias, Pegoraro, Francesca, Sanchez, Stephane, Bouché, Olivier, Kianmanesh, Reza, Piardi, Tullio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640996/ https://www.ncbi.nlm.nih.gov/pubmed/36387257 http://dx.doi.org/10.3389/fonc.2022.980659

Ejemplares similares

Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma
por: Brugel, M., et al.
Publicado: (2021)

Is there a place for microwave ablation under Pringle maneuver for perivascular colorectal liver metastases?: Reponse to “ Laparoscopic liver resection for liver tumors in proximity to major vasculature: A single-center comparative study”
por: Rhaiem, Rami, et al.
Publicado: (2020)

Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases
por: Rhaiem, Rami, et al.
Publicado: (2022)

Microwave Ablation for Colorectal Liver Metastases: A Systematic Review and Pooled Oncological Analyses
por: Mimmo, Antonio, et al.
Publicado: (2022)

Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer
por: Jeon, Hyun Jeong, et al.
Publicado: (2023)

Sequential treatment of rupture of pseudoaneurysm of hepatic artery with peritoneal patch and radiological embolization
por: Tashkandi, A, et al.
Publicado: (2019)

Laparoscopic hybrid pancreaticoduodenectomy: Initial single center experience
por: Al-Sadairi, Abdul Rahman, et al.
Publicado: (2021)

Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
por: Shrestha, Bikram, et al.
Publicado: (2017)

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
por: Versteijne, E., et al.
Publicado: (2018)

Preoperative magnetic resonance cholangiopancreatography before planned laparoscopic cholecystectomy: is it necessary?
por: Rhaiem, Rami, et al.
Publicado: (2019)

Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications
por: Deig, Christopher Ryan, et al.
Publicado: (2022)

Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer
por: Kim, Hyeong Seok, et al.
Publicado: (2017)

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
por: Hu, Qiancheng, et al.
Publicado: (2019)

Asymptomatic stenosis of a celiacomesenteric trunk
por: Hammoutene, Cheryne, et al.
Publicado: (2022)

Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
por: Miksch, Rainer C., et al.
Publicado: (2019)

Prolonged inpatient stay after upfront total laryngectomy is associated with overall survival
por: Jacobs, Daniel, et al.
Publicado: (2021)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
por: Mikulic, Danko, et al.
Publicado: (2021)

Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
por: Ono, Kosuke, et al.
Publicado: (2021)

The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With Nodal Metastases
por: Altman, Ariella M., et al.
Publicado: (2022)

Robotic Liver Resection as a Bridge to Liver Transplantation
por: Panaro, Fabrizio, et al.
Publicado: (2011)

Nomogram to predict overall survival after gallbladder cancer resection in China
por: Bai, Yi, et al.
Publicado: (2018)

Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?
por: Sweigert, Patrick J., et al.
Publicado: (2020)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
por: Song, Jianyuan, et al.
Publicado: (2020)

Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
por: Nichols, Romaine Charles, et al.
Publicado: (2019)

Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma
por: Ma, Kexin, et al.
Publicado: (2019)

Predictive factors for resection and survival in type A borderline resectable pancreatic ductal adenocarcinoma patients after neoadjuvant therapy: A retrospective cohort study
por: Secanella, Luis, et al.
Publicado: (2022)

Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis
por: Pan, Long, et al.
Publicado: (2019)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Glioblastoma: A Retrospective Analysis of the Role of the Maximal Surgical Resection on Overall Survival and Progression Free Survival
por: Polonara, Gabriele, et al.
Publicado: (2023)

High amylase concentration in drainage liquid can early predict proximal and distal intestinal anastomotic leakages: A prospective observational study
por: Amroun, Koceila, et al.
Publicado: (2023)

Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival
por: Angelsen, Jon-Helge, et al.
Publicado: (2014)

Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection
por: Lin, Chih-Wen, et al.
Publicado: (2018)

A 25-gene classifier predicts overall survival in resectable pancreatic cancer
por: Birnbaum, David J., et al.
Publicado: (2017)

Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS(ICC)‐applied prediction model
por: Tian, Mengxin, et al.
Publicado: (2020)

Nomogram predicting overall survival after surgical resection for retroperitoneal leiomyosarcoma patients
por: Zhuang, Aojia, et al.
Publicado: (2023)

Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry
por: Nooijen, Lynn E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ptc8efu4l0pp8lc6qfv9385d3